Orlando, FL - The enhanced external counterpulsation device therapy known as EECP® (Vasomedical Inc), which is struggling for acceptance as a mainstream intervention for angina and heart failure, ...
The present study showed that when carefully applied and monitored, the application of 35 1-hour daily sessions of EECP over approximately 7 weeks was safe and well-tolerated in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback